Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04553562
Other study ID # 2019-248-KY
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 1, 2021
Est. completion date December 31, 2023

Study information

Verified date November 2021
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact Zhishun Liu, PhD
Phone 86-010-88002331
Email liuzhishun@aliyun.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pelvic pain (CPP) is one of the common symptoms of women at childbearing age. The aim of this study is to assess the efficacy of acupuncture for female with non-cyclic chronic pelvic pain. A three-arm randomized controlled trial (RCT) using acupuncture, sham acupuncture and waiting list with a total sample of 150 will be conducted.


Description:

Chronic pelvic pain (CPP) is a persistent pain in pelvis, anterior abdominal wall, lower back, or buttocks lasting at least six months. According to a WHO epidemiological study, the worldwide prevalence rate of CPP in childbearing age women was 2.1%-24%. At present, nearly 55% of the patients had unclear etiology, and there is no universally accepted diagnosis, evaluation and treatment. CPP is often associated with gynecological and non gynecological diseases, including endometriosis, abdominal visceral adhesion, myofascial pain and dysfunction, irritable bowel syndrome and interstitial cystitis/bladder pain syndrome. CPP are also accompanied by psychological and physiological dysfunction, the most common is depression and anxiety, which seriously affects the quality of life of patients. Acupuncture may have effect on non-cyclic CPP in female, however, there is a lack of evidence of effectiveness of acupuncture. A multi-center randomized three-armed controlled trial will be conducted. The aim of this study is assess the efficacy and safety of acupuncture for female patients with non-cyclic CPP.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date December 31, 2023
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Meet the diagnostic criteria of non-cyclic CPP. - Age 18 to 50 years. - Have moderate to severe pain in pelvis, anterior abdominal wall, lower back, or buttocks lasting at least six months. - The mean degree of pelvic pain in the past week rated by Visual Analogue Scale is =40 scores. - Sign informed consent and participate in the study voluntarily. Exclusion Criteria: - Have endometriosis (including adenomyosis), ovarian cyst (larger than 3cm), hysteromyoma (larger than 3cm), severe pelvic adhesion, pelvic malignant tumor (relevant examination must be within the last 6 months). - Have acute pelvic/urinary tract infection. - Have pain after pelvic surgery. - Have recurrent gastrointestinal or bladder diseases such as irritable bowel syndrome, interstitial cystitis / bladder pain syndrome, etc. - During pregnancy or in lactation or have a pregnancy plan within 8 months. - Have heart, lung, liver, kidney, mental disorders or cognitive dysfunction. - Have acupuncture treatment in recent 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Acupuncture
Sterile adhesive pads will be placed after skin disinfection on the acupoints. Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) will be inserted through the pads by the needles (0.30mm in diameter, 40 mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 25-30mm. Yintang (GV4) will be inserted through the pads by the needle (0.30mm in diameter, 25mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 10-15mm. The needles at all points will be lightly lifting, thrusting, and twirling every 10 minutes during each session with the sensation of sourness, achiness, heaviness and numbness (deqi). The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.
Sham acupuncture
Sterile adhesive pads will be placed after skin disinfection on the acupoints. Needles (0.30 mm in diameter, 25 mm in length) with a blunt tip will be inserted at the Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) without penetrating the skin. The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Outcome

Type Measure Description Time frame Safety issue
Other Blinding assessment To test the success of blinding, participants in the acupuncture group and the SA group will be asked to reply to the following question at the 6th week of treatment (sessions 18): "Do you think you have received traditional acupuncture in the past weeks?" The participants will be able to choose one of the following options as the answer: "Yes", "No" or "Unclear". Week 6
Other Safety assessment We will handle and document the adverse events (AEs) using the standard operating procedures for monitoring and reporting all AEs. According to their potential association with the treatment, AEs will be categorized as treatment-related or non-treatment-related within 24 hours after their occurrence. Treatment-related AEs include pain, haematoma, localized infection, broken needle, fainting, nausea, headache, dizziness, insomnia, vomiting, or palpitations during or after treatment. In addition, adverse events that are irrelevant to the treatment will be recorded during the study period. Week 0 to 30
Other Expectation of improvement assessment Patients choosing "improved" in the expectation assessment will be asked: "To what extent do you think your pelvic pain will be helped after acupuncture treatment?" Participants will choose the answer from the following options: a great degree, a moderate degree, a small degree, unclear. Baseline
Other Trust evaluation of acupuncture therapy Patients choosing "improved" in the expectation assessment will be asked: "To what extent do you think your pelvic pain will be helped after acupuncture treatment?" Participants will choose the answer from the following options: a great degree, a moderate degree, a small degree, unclear. Baseline and week 6
Primary The change from baseline of the mean score in the past week of the Visual Analogue Scale The scores of the Visual Analogue Scale range from 0 to 10,higher scores mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the Brief Pain Inventory score The Brief Pain Inventory score uses 0-10 numeric scales for item rating with 0 being "no pain" and 10 being "pain as bad as you can imagine". The pain severity score is calculated from the four items about pain intensity with a range from 0 to 40. The pain interference score corresponds to the item on pain interference with a range from 0 to 70. Higher scores of the Brief Pain Inventory mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the pain severity score of the Brief Pain Inventory The pain severity score of the Brief Pain Inventory is calculated from the four items about pain intensity. Each item is rated from "no pain" to "pain as bad as you can imagine", and contributes with the same weight to the final score, ranging from 0 to 40. The pain interference score corresponds to the item on pain interference. Higher scores of the The pain severity score mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the pain interference score of the Brief Pain Inventory The pain interference score of the Brief Pain Inventory corresponds to the item on pain interference. The seven subitems are rated from "does not interfere" to "completely interferes", and contributes with the same weight to the final score, ranging from 0 to 70. Higher scores of the pain interference score mean a worse outcome. Week 6, 18 and 30
Secondary The proportion of patients with decrease of 0.6 score or more from baseline of the pain interference score of the Brief Pain Inventory The pain interference score of the Brief Pain Inventory corresponds to the item on pain interference. The seven subitems are rated from "does not interfere" to "completely interferes", and contributes with the same weight to the final score, ranging from 0 to 70. Higher scores of the pain interference score mean a worse outcome. Week 6, 18 and 30
Secondary The proportion of patients with decrease of 20% or more from baseline of the pain severity score of the Brief Pain Inventory The pain severity score of the Brief Pain Inventory is calculated from the four items about pain intensity. Each item is rated from "no pain" to "pain as bad as you can imagine", and contributes with the same weight to the final score, ranging from 0 to 40. The pain interference score corresponds to the item on pain interference. Higher scores of the The pain severity score mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the Pain Catastrophising Questionnaire score The Pain Catastrophising Questionnaire is a validated scale with 13 items, each scored from 0 (not at all) to 4 (all the time) with a total score range of 0-52, across three domains: rumination (0-16); magnifications (0-12); and helplessness (0-24).Higher scores of the Pain Catastrophising Questionnaire mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the Hospital Anxiety and Depression Scale score the score of the Hospital Anxiety and Depression Scale ranges from 0 to 42. Higher scores mean a worse outcome. Week 6, 18 and 30
Secondary The change from baseline of the World Health Organisation Quality of life - Bref Questionnaire score Domain scores for the World Health Organisation Quality of life-Bref Questionnaire score are calculated by taking the mean of all items included in each domain and multiplying by a factor of four. These scores are then transformed to a 0-100 scale.Higher scores denote higher quality of life. Week 6, 18 and 30
Secondary The proportions of participants in each response category of the Patient global impression of change Patient global impression of change consists of 7 response categories with a range of 1-7: "very much improved," "much improved," "minimally improved," "no change," "minimally worse," "much worse," or "very much worse." Higher scores mean a worse outcome. Week 6, 18 and 30
Secondary The proportion of subjects using rescue medications and the duration of medication use The use of medications during this trial. However, medication use is allowed for intolerable symptoms as long as it is recorded accordingly, including the name, the dosage, and the duration of the medication use. Week 6, 18 and 30
See also
  Status Clinical Trial Phase
Completed NCT03638856 - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT01020162 - Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain N/A
Recruiting NCT05836454 - The Soft Tissue Mobilization Techniques on PMS N/A
Completed NCT02372903 - Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis N/A
Recruiting NCT05185180 - Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Recruiting NCT05970783 - A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease Phase 3
Completed NCT04615247 - Program to Overcome Pelvic Pain Study N/A
Completed NCT02721108 - Mindfulness Meditation for Chronic Pelvic Pain Management N/A
Not yet recruiting NCT00844012 - Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain Phase 4
Recruiting NCT04976751 - Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China Phase 1
Withdrawn NCT04252040 - Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP) N/A
Completed NCT01802528 - Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients N/A
Completed NCT03175809 - Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain N/A
Recruiting NCT05324280 - Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain N/A
Not yet recruiting NCT02556411 - Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS) N/A
Completed NCT04104542 - MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women N/A
Completed NCT01553201 - Botulinum Toxin for Pelvic Pain in Women With Endometriosis Phase 1/Phase 2
Completed NCT03617627 - Self-management Program in Chronic Pelvic Pain N/A
Recruiting NCT06019091 - Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults N/A